Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

2608

LikeLikedUnlike

Episodes 31-45 of 745

Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CE
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
- Scott Solomon, MD
  Peer
0.25 credits
Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
CME/CE
Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
- Roy F. Chemaly, MD, MPH, FIDSA, FACP
  Peer
- Atul Humar, MD, FRCPC, FAST
  Peer
1.50 credits
MinuteCE®
CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
- Kathleen Moore, MD, MS
  Peer
- Joyce F. Liu, MD, MPH
  Peer
0.50 credits 5 episodes
The Fifth Pillar? Closing the Gap in HFrEF
CME/CE
The Fifth Pillar? Closing the Gap in HFrEF
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
- Javed Butler, MD
  Peer
- Stephen J. Greene, MD, FACC, FHFSA
  Peer
0.50 credits
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
MinuteCE®
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
- Joyce F. Liu, MD, MPH
  Peer
0.50 program credits
MOA: CDH6-Targeted Antibody-Drug Conjugates
MinuteCE®
MOA: CDH6-Targeted Antibody-Drug Conjugates
- Kathleen Moore, MD, MS
  Peer
0.50 program credits
advertisement
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
MinuteCE®
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
- Joyce F. Liu, MD, MPH
  Peer
0.50 program credits
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
MinuteCE®
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
- Kathleen Moore, MD, MS
  Peer
0.50 program credits
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
MinuteCE®
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
- Joyce F. Liu, MD, MPH
  Peer
- Kathleen Moore, MD, MS
  Peer
0.50 program credits
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
CME/CE
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
- Christyn Edmundson, MD
  Peer
- Neelam Goyal, MD
  Peer
0.25 credits
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
CME/CE
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
- Naim Alkhouri, MD, FAASLD, DABOM
  Peer
0.25 credits
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
CME/CE
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
- Joshua Richter, MD
  Peer
1.00 credits
advertisement
Updates in Major Depressive Disorder with Insomnia
CME/CE
Updates in Major Depressive Disorder with Insomnia
- Michael E. Thase, MD
  Peer
- Andrew Krystal, MD
  Peer
0.50 credits
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CE
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
- Stephen Chrzanowski, MD, PhD
  Peer
- Aravindhan Veerapandiyan, MD
  Peer
1.00 credits
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum 
CME/CE
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum 
- prof. Hiddo Heerspink
  Peer
- Peter Rossing, MD, DMSc
  Peer
- Paola Fioretto, MD
  Peer
0.50 credits

Program Chapters

Segment Chapters

Playlist:

Recommended